{"filings":[{"id":92074,"accession_number":"0001104659-26-053056","cik":1320414,"company_name":"SELECT MEDICAL HOLDINGS CORP","ticker":"SEM","form_type":"8-K","filed_at":"2026-04-30T23:59:59+00:00","items":["2.02","5.02","8.01","9.01"],"status":"ready","headline":"Select Medical Q1 EPS $0.35 vs $0.44; revenue +5% to $1.42B; merger on track","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $1,421.5M +5.0% YoY; net income $63.8M vs $74.7M; diluted EPS $0.35 vs $0.44.","Adj EBITDA $141.6M down from $151.4M; critical illness hospital margin fell to 11.5% from 13.6%.","Rehab hospital revenue +14.5% to $351.9M, Adj EBITDA +15.1% to $81.1M, margin stable at 23.0%.","Merger with WCAS XIV on track; HSR waiting period expired Apr 27; expected close mid-2026 at $16.50/share.","FY 2026 outlook reaffirmed: rev $5.6-5.8B, Adj EBITDA $520-540M, diluted EPS $1.22-1.32."],"consensus_eps_estimate":null,"consensus_eps_actual":0.35,"consensus_revenue_estimate":null,"consensus_revenue_actual":1421476000.0,"consensus_period":"2026-Q1","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":2045678501.216232,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":92073,"accession_number":"0001104659-26-048634","cik":1320414,"company_name":"SELECT MEDICAL HOLDINGS CORP","ticker":"SEM","form_type":"8-K","filed_at":"2026-04-24T23:59:59+00:00","items":["5.07","9.01"],"status":"ready","headline":"Select Medical shareholders approve board declassification, special meeting at 25% threshold","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Three Class II directors elected with >98% support; say-on-pay approved with 97% of votes cast.","Amendment to phase out classified board approved (113.8M for, 233,759 against); board will become annually elected.","Company special meeting at 25% threshold passed (96.4M for); shareholder proposal at 10% threshold rejected (91.2M against).","Ratification of PwC as auditor for FY2026 approved (116.3M for, 1.5M against)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.15,"market_cap_usd":2045678501.216232,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":102615,"accession_number":"0001104659-26-022577","cik":1320414,"company_name":"SELECT MEDICAL HOLDINGS CORP","ticker":"SEM","form_type":"8-K","filed_at":"2026-03-03T23:59:59+00:00","items":["1.01","7.01","9.01"],"status":"ready","headline":"Select Medical to be acquired by consortium led by Ortenzio, Jackson, WCAS for $16.50/share","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Enterprise value of $3.9B; Merger Consideration of $16.50 per share in cash.","Premium of ~18% over unaffected price (Nov 24, 2025) and ~25% over 90-day VWAP.","Ortenzio, Jackson and certain affiliates rolling over ~11.8% equity stakes; will vote in favor.","Closing expected mid-2026, subject to stockholder approval, HSR, and regulatory clearances.","Company termination fee $66.5M; Parent termination fee $133.0M."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":2045678501.216232,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":102614,"accession_number":"0001104659-26-017585","cik":1320414,"company_name":"SELECT MEDICAL HOLDINGS CORP","ticker":"SEM","form_type":"8-K","filed_at":"2026-02-19T23:59:59+00:00","items":["2.02","8.01","9.01"],"status":"ready","headline":"Select Medical reports Q4 growth, 2026 outlook; Ortenzio take-private bid under review","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 revenue $1,396.6M (+6.4%), net income $37.7M, diluted EPS $0.16 vs loss $0.19 YoY.","FY2025 revenue $5,452.8M (+5.1%), net income $214.5M (+65%), adjusted EPS $1.16 (+23.4%).","Rehab hospital segment revenue +15.2%, Adj EBITDA +11.1%. Outpatient rehab margin fell to 3.4% from 8.3%.","2026 outlook: revenue $5.6-5.8B, Adj EBITDA $520-540M, diluted EPS $1.22-1.32.","Board declares $0.0625 dividend; $1B stock repurchase authorized through Dec 2027; Ortenzio take-private proposal under review."],"consensus_eps_estimate":null,"consensus_eps_actual":1.16,"consensus_revenue_estimate":null,"consensus_revenue_actual":5452830000.0,"consensus_period":"2025-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":2045678501.216232,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":118858,"accession_number":"0001104659-25-123153","cik":1320414,"company_name":"SELECT MEDICAL HOLDINGS CORP","ticker":"SEM","form_type":"8-K","filed_at":"2025-12-19T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Select Medical enters new CEO employment agreement with Thomas Mullin effective Jan 1, 2026","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["1-year initial term, auto-renewing; base salary $700,000/year.","Termination without cause: 12 months base salary continuation.","Non-compete and non-solicitation covenants apply for 2 years post-termination.","Change of control terms governed by prior February 2021 letter."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":2045678501.216232,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":118857,"accession_number":"0001104659-25-115701","cik":1320414,"company_name":"SELECT MEDICAL HOLDINGS CORP","ticker":"SEM","form_type":"8-K","filed_at":"2025-11-25T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Select Medical receives take-private proposal from Executive Chairman at $16-$16.20/share","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Non-binding proposal to acquire all outstanding shares for $16.00-$16.20 cash per share.","Proposal submitted by Robert A. Ortenzio, Executive Chairman, Co-Founder, and Director, via Schedule 13D.","Disinterested board members are reviewing the proposal with advisors.","No assurance of outcome; company will not comment further unless required."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":2045678501.216232,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":118856,"accession_number":"0001104659-25-104425","cik":1320414,"company_name":"SELECT MEDICAL HOLDINGS CORP","ticker":"SEM","form_type":"8-K","filed_at":"2025-10-30T23:59:59+00:00","items":["2.02","8.01","9.01"],"status":"ready","headline":"Select Medical Q3 revenue up 7.2% to $1.36B, EPS $0.23; raises FY25 EPS guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q3 revenue $1,363.4M (+7.2% YoY); income from cont ops $44.2M (+7%); Adj EBITDA $111.7M (+7.5%).","EPS from cont ops $0.23 vs $0.19 (+21.1%); adjusted EPS $0.23 vs $0.26 (-11.5%).","Rehab hospital rev +16.2% to $328.6M; outpatient rehab EBITDA margin fell to 7.4% from 9.1%.","FY25 outlook: revenue $5.3-5.5B, Adj EBITDA $510-530M, diluted EPS $1.14-1.24 (raised).","Dividend $0.0625/share declared; stock buyback program extended to Dec 31, 2027."],"consensus_eps_estimate":null,"consensus_eps_actual":1.0,"consensus_revenue_estimate":null,"consensus_revenue_actual":4056196000.0,"consensus_period":"2025-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":2045678501.216232,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":135393,"accession_number":"0001104659-25-086392","cik":1320414,"company_name":"SELECT MEDICAL HOLDINGS CORP","ticker":"SEM","form_type":"8-K","filed_at":"2025-09-02T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Select Medical names Thomas P. Mullin CEO; David Chernow becomes Vice Chairman","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Mullin, 41, promoted from Co-President, effective Sept 1, 2025; Chernow (CEO since 2014) becomes Vice Chairman.","John A. Saich becomes sole President (was Co-President); retains oversight of outpatient rehab and shared services.","John F. Duggan appointed EVP, General Counsel and Secretary; Michael Tarvin transitions to senior EVP of legal services.","Mullin joined Select Medical in 2008, most recently oversaw 140 critical illness recovery and inpatient rehab hospitals.","All changes effective immediately; company cites internal succession planning with long-tenured leaders."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":2045678501.216232,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":135392,"accession_number":"0001104659-25-073383","cik":1320414,"company_name":"SELECT MEDICAL HOLDINGS CORP","ticker":"SEM","form_type":"8-K","filed_at":"2025-08-04T23:59:59+00:00","items":["5.03","9.01"],"status":"ready","headline":"Select Medical amends bylaws to tighten stockholder nomination rules under universal proxy","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Board adopted Amended and Restated Bylaws on July 30, 2025.","Stockholders must now represent intent to solicit proxies from at least 67% voting power for director elections.","Stockholders must provide evidence of proxy solicitation to the company.","Amendments also clarify and enhance other advanced notice procedural requirements.","Changes align with SEC Rule 14a-19 under the universal proxy framework."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":2045678501.216232,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":135391,"accession_number":"0001104659-25-072731","cik":1320414,"company_name":"SELECT MEDICAL HOLDINGS CORP","ticker":"SEM","form_type":"8-K","filed_at":"2025-07-31T23:59:59+00:00","items":["2.02","8.01","9.01"],"status":"ready","headline":"Select Medical Q2 revenue +4.5% to $1.34B, EPS $0.32, reaffirms FY2025 outlook","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $1,339.6M (+4.5% YoY); net income from continuing ops $57.9M (+53.8%).","Adjusted EBITDA $125.4M (+0.5% YoY); diluted EPS $0.32 vs $0.17 (+88.2%).","Rehab hospital revenue +17.2% to $313.8M; critical illness revenue -0.6% to $601.1M.","Reaffirms FY2025 revenue $5.3B-$5.5B, Adj EBITDA $510M-$530M, EPS $1.09-$1.19.","Declares $0.0625/share cash dividend (payable Aug 28); $1B buyback program ongoing."],"consensus_eps_estimate":null,"consensus_eps_actual":0.76,"consensus_revenue_estimate":null,"consensus_revenue_actual":2692751000.0,"consensus_period":"2025-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":2045678501.216232,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":152378,"accession_number":"0001104659-25-043544","cik":1320414,"company_name":"SELECT MEDICAL HOLDINGS CORP","ticker":"SEM","form_type":"8-K","filed_at":"2025-05-01T23:59:59+00:00","items":["2.02","8.01","9.01"],"status":"ready","headline":"Select Medical Q1 revenue up 2.4%, EPS rises 33% but core segment weakens; guidance lowered","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $1,353.2M (+2.4% YoY); net income from cont. ops $74.7M (+21.5%); EPS $0.44 (+33.3%).","Critical illness recovery hospital revenue declined 2.9% to $637.0M, segment Adjusted EBITDA down 25.3% to $86.6M.","Rehabilitation hospital revenue up 15.7% to $307.4M, segment Adjusted EBITDA up 14.7% to $70.4M.","Declared quarterly dividend $0.0625/share, payable May 29 to holders of record May 15.","FY2025 guidance lowered: revenue $5.3B-$5.5B (prev. $5.4B-$5.6B), Adj. EBITDA $510M-$530M (prev. $530M-$550M)."],"consensus_eps_estimate":null,"consensus_eps_actual":0.44,"consensus_revenue_estimate":null,"consensus_revenue_actual":1353172000.0,"consensus_period":"2025-Q1","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":2045678501.216232,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":152377,"accession_number":"0001104659-25-041376","cik":1320414,"company_name":"SELECT MEDICAL HOLDINGS CORP","ticker":"SEM","form_type":"8-K","filed_at":"2025-04-29T23:59:59+00:00","items":["5.02","5.03","5.07","9.01"],"status":"ready","headline":"Select Medical shareholders approve director comp policy and eliminate supermajority voting","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Stockholders approved a Non-Employee Director Compensation Policy with $18,000 quarterly cash retainer and $200,000 annual equity grant.","Charter amended to eliminate supermajority voting requirements; voting threshold reduced to majority of outstanding shares.","Bylaws amended to reduce voting threshold to majority for amending bylaws and removing directors for cause.","Four Class I directors elected: Russell Carson, Katherine Davisson, William Frist, Marilyn Tavenner."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"market_cap_usd":2045678501.216232,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":171214,"accession_number":"0001104659-25-015705","cik":1320414,"company_name":"SELECT MEDICAL HOLDINGS CORP","ticker":"SEM","form_type":"8-K","filed_at":"2025-02-20T23:59:59+00:00","items":["2.02","8.01","9.01"],"status":"ready","headline":"Select Medical Q4 revenue +7.8% to $1.31B, adjusted EPS +50%; issues 2025 outlook","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 revenue $1.31B (+7.8% YoY); loss from continuing ops $10.5M vs profit $30.3M (impacted by $45.9M stock comp acceleration and $17.9M debt retirement loss).","Adjusted EPS from continuing ops $0.18 (+50% YoY); full-year adjusted EPS $0.94 (+74.1%).","Rehabilitation hospital segment Q4 margin declined to 21.2% from 25.5%; outpatient rehab full-year margin down to 8.7% from 9.4%.","Completed tax-free distribution of Concentra; no longer owns any shares.","2025 outlook: revenue $5.4-5.6B, Adj EBITDA $520-540M, diluted EPS $1.09-1.19."],"consensus_eps_estimate":null,"consensus_eps_actual":1.66,"consensus_revenue_estimate":null,"consensus_revenue_actual":5187105000.0,"consensus_period":"2024-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":2045678501.216232,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":188185,"accession_number":"0001104659-24-125495","cik":1320414,"company_name":"SELECT MEDICAL HOLDINGS CORP","ticker":"SEM","form_type":"8-K","filed_at":"2024-12-04T23:59:59+00:00","items":["1.01","2.03","8.01","9.01"],"status":"ready","headline":"Select Medical closes $550M 6.250% senior notes due 2032; amends credit agreement with $1.05B term loan","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Net proceeds used to repay existing term loans and redeem all outstanding 6.250% Senior Notes due 2026.","Amendment No. 11 adds $1.05B incremental term loan and extends revolver to 5 years; $50M incremental revolver commitment added.","Interest on new notes is 6.250% payable semi-annually; matures December 2032."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":2045678501.216232,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":188184,"accession_number":"0001104659-24-123173","cik":1320414,"company_name":"SELECT MEDICAL HOLDINGS CORP","ticker":"SEM","form_type":"8-K","filed_at":"2024-11-26T23:59:59+00:00","items":["2.01","9.01"],"status":"ready","headline":"Select Medical completes spin-off of Concentra, distributing 104M shares worth $2.3B","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["104,093,503 shares of Concentra (81.7% stake) distributed to Select stockholders as of Nov 18 record date.","Stockholders received 0.806971 Concentra shares per Select share; cash in lieu of fractional shares.","Aggregate market value of distributed shares ~$2.3B based on $22.13 closing price on Nov 25, 2024.","Pro forma financials reflect separation; planned $550M 6.250% notes due 2032 and $1.05B term loan to repay debt.","After distribution, Select Medical holds no shares of Concentra common stock."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":2045678501.216232,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":188183,"accession_number":"0001104659-24-120415","cik":1320414,"company_name":"SELECT MEDICAL HOLDINGS CORP","ticker":"SEM","form_type":"8-K","filed_at":"2024-11-19T23:59:59+00:00","items":["1.01","8.01","9.01"],"status":"ready","headline":"Select Medical Corp prices $550M of 6.250% Senior Notes due 2032 to refinance existing debt","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["$550M aggregate principal of 6.250% Senior Notes due 2032 priced; closing expected Dec 3, 2024.","Notes are senior unsecured obligations guaranteed by certain domestic subsidiaries.","Proceeds will repay existing term loans and redeem all outstanding 6.250% Senior Notes due 2026.","Concurrently, Select intends to amend its credit agreement to add incremental term loan and extend revolving credit maturity.","Offering is private under Rule 144A/Reg S; notes not registered."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":2045678501.216232,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":188182,"accession_number":"0001104659-24-120386","cik":1320414,"company_name":"SELECT MEDICAL HOLDINGS CORP","ticker":"SEM","form_type":"8-K","filed_at":"2024-11-19T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Select Medical sets final distribution ratio of 0.806971 Concentra shares per SEM share; distribution Nov 25","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Final ratio: 0.806971 shares of Concentra (CON) per SEM share; based on 128,992,850 SEM shares outstanding as of Record Date Nov 18.","Distribution of 104,093,503 CON shares (81.7% of CON) on Nov 25; no fractional shares, cash in lieu.","After distribution, Select Medical will own no CON shares; distribution intended tax-free for U.S. holders.","Shares trade with due bills in regular-way market through Distribution Date; ex-distribution market also available."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":2045678501.216232,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":188181,"accession_number":"0001104659-24-119970","cik":1320414,"company_name":"SELECT MEDICAL HOLDINGS CORP","ticker":"SEM","form_type":"8-K","filed_at":"2024-11-18T23:59:59+00:00","items":["7.01","8.01","9.01"],"status":"ready","headline":"Select Medical Corp. announces $850M senior notes offering and $750M term loan to refinance existing debt","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Select Medical Corporation plans $850M senior notes due 2032 in a private placement; notes guaranteed by certain domestic subsidiaries.","Concurrently, it will amend credit facilities to add a $750M incremental term loan, extend revolver to 5 years, and add $50M revolver.","Proceeds from notes, new term loan, and cash on hand will repay existing term loan and redeem all outstanding 6.250% senior notes due 2026.","The offering is subject to market conditions and other customary conditions; no assurance it will be completed as described."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":2045678501.216232,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":188180,"accession_number":"0001104659-24-114906","cik":1320414,"company_name":"SELECT MEDICAL HOLDINGS CORP","ticker":"SEM","form_type":"8-K","filed_at":"2024-11-07T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Select Medical spins off 81.7% Concentra stake via special stock distribution","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Distribution of 104,093,503 Concentra shares (81.7% of CON) to SEM stockholders on Nov 25, 2024.","Record date Nov 18, 2024; stockholders receive ~0.806971 CON shares per SEM share.","No stockholder vote required; distribution intended to be tax-free for U.S. federal income tax purposes.","After distribution, Select Medical will own no shares of Concentra common stock.","J.P. Morgan and Goldman Sachs acting as financial advisors; Dechert LLP as legal advisor."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":2045678501.216232,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":188179,"accession_number":"0001104659-24-113096","cik":1320414,"company_name":"SELECT MEDICAL HOLDINGS CORP","ticker":"SEM","form_type":"8-K","filed_at":"2024-10-31T23:59:59+00:00","items":["2.02","8.01","9.01"],"status":"ready","headline":"Select Medical Q3 revenue up 5.7% to $1.76B; net income +33.2%; dividend $0.125; FY guidance updated","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q3 revenue $1,761.2M (+5.7% YoY); net income $81.0M (+33.2%); adjusted EPS $0.50 (+8.7%).","Segment Adj. EBITDA: Critical Illness +9.5%, Rehab Hospital +12.1%, Concentra +2.7%.","FY2024 guidance: revenue $6.95B–$7.15B; Adj. EBITDA $865M–$885M; adj. EPS $2.09–$2.20.","Dividend $0.125/share declared, payable Nov 26 to holders of record Nov 13, 2024.","No share repurchases in Q3; $600.3M total buybacks since program inception."],"consensus_eps_estimate":null,"consensus_eps_actual":1.78,"consensus_revenue_estimate":null,"consensus_revenue_actual":5309692000.0,"consensus_period":"2024-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":2045678501.216232,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":204681,"accession_number":"0001104659-24-084960","cik":1320414,"company_name":"SELECT MEDICAL HOLDINGS CORP","ticker":"SEM","form_type":"8-K","filed_at":"2024-08-01T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Director Ortenzio resigns; CEO Chernow appointed to board","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Rocco Ortenzio resigned as director effective August 1, 2024, with no disagreement with the company.","CEO David Chernow appointed as director effective August 1, 2024 to fill the vacancy; remains CEO.","Chernow's director term expires at the 2027 annual meeting; no special arrangement with any person."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":2045678501.216232,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":204680,"accession_number":"0001104659-24-084955","cik":1320414,"company_name":"SELECT MEDICAL HOLDINGS CORP","ticker":"SEM","form_type":"8-K","filed_at":"2024-08-01T23:59:59+00:00","items":["2.02","8.01","9.01"],"status":"ready","headline":"Select Medical Q2 revenue up 5.1% to $1.76B, EPS $0.60; Concentra IPO raises $528.8M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q2 rev $1,759.7M (+5.1% YoY), net income $94.8M (+3.2%), GAAP EPS $0.60 vs $0.61 prior.","Adj EBITDA $226.3M (+3.1%); FY2024 guidance reaffirmed (rev $6.9-7.1B, adj EPS $1.96-2.20).","Concentra IPO raised $528.8M (22.5M shares at $23.50); also issued $650M 6.875% Senior Notes due 2032.","IPO & debt proceeds repaid $1.9B of Select credit facilities; $0.125/shr dividend declared."],"consensus_eps_estimate":null,"consensus_eps_actual":1.35,"consensus_revenue_estimate":null,"consensus_revenue_actual":3548472000.0,"consensus_period":"2024-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":2045678501.216232,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":204679,"accession_number":"0001104659-24-084488","cik":1320414,"company_name":"SELECT MEDICAL HOLDINGS CORP","ticker":"SEM","form_type":"8-K","filed_at":"2024-08-01T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"Select Medical completes Concentra IPO of 22.5M shares at $23.50, retains ~82% stake","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["IPO of 22.5M shares of Concentra common stock at $23.50/share; net proceeds $499.7M.","IPO proceeds paid to SMC to repay intercompany debt; SMC retains ~82.23% of Concentra.","Select credit agreement amended; revolving commitments reduced from $770M to $550M.","Concentra entered into $1.25B credit facilities ($850M term loan, $400M revolver).","Concentra assumed $650M of 6.875% senior notes due 2032."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":2045678501.216232,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":204678,"accession_number":"0001104659-24-080552","cik":1320414,"company_name":"SELECT MEDICAL HOLDINGS CORP","ticker":"SEM","form_type":"8-K","filed_at":"2024-07-17T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"Select Medical subsidiary issues $650M 6.875% Senior Notes due 2032","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["$650M aggregate principal of 6.875% senior notes due July 15, 2032, issued by Concentra Escrow Issuer Corp.","$50M of net proceeds for general corporate purposes; remainder paid to Select Medical Corp as a dividend.","Notes are part of financing for planned separation of Concentra; merger with Concentra Health Services pending.","If merger not consummated by Sep 30, 2024, notes subject to special mandatory redemption at 100% plus accrued interest.","Interest payable semi-annually on Jan 15 and Jul 15, starting Jan 15, 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":2045678501.216232,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":204677,"accession_number":"0001104659-24-079579","cik":1320414,"company_name":"SELECT MEDICAL HOLDINGS CORP","ticker":"SEM","form_type":"8-K","filed_at":"2024-07-12T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Select Medical estimates Concentra Q2 rev $477.9M, op income $83.9M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Concentra net operating revenue ~$477.9M for Q2 2024; income from operations ~$83.9M.","Estimates are preliminary, subject to change upon completion of financial close.","Select Medical's full Q2 2024 results expected after market close on August 1, 2024.","Conference call to discuss results and outlook on August 2, 2024."],"consensus_eps_estimate":null,"consensus_eps_actual":1.35,"consensus_revenue_estimate":null,"consensus_revenue_actual":3548472000.0,"consensus_period":"2024-Q2","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":2045678501.216232,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":221519,"accession_number":"0001104659-24-075765","cik":1320414,"company_name":"SELECT MEDICAL HOLDINGS CORP","ticker":"SEM","form_type":"8-K","filed_at":"2024-06-27T23:59:59+00:00","items":["1.01","7.01","9.01"],"status":"ready","headline":"Select Medical's Concentra subsidiary prices $650M of 6.875% senior notes due 2032","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["$650M aggregate principal of 6.875% senior notes due 2032 priced by Concentra Escrow Issuer.","Notes issued as a step in the planned separation of Concentra from Select Medical.","Proceeds held in escrow pending merger into CHSI expected Q3 2024; if not closed by Sep 30, notes subject to special mandatory redemption at 100% plus accrued interest.","Concentra to use $50M for corporate purposes; remainder plus borrowings paid as dividend to Select Medical Corp.","Upon merger, notes guaranteed by Concentra and certain subsidiaries on senior unsecured basis."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":2045678501.216232,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":221518,"accession_number":"0001104659-24-056432","cik":1320414,"company_name":"SELECT MEDICAL HOLDINGS CORP","ticker":"SEM","form_type":"8-K","filed_at":"2024-05-02T23:59:59+00:00","items":["2.02","8.01","9.01"],"status":"ready","headline":"Select Medical reports Q1 2024 revenue $1.79B (+7.4%), adj EPS $0.77 (+37.5%); declares $0.125 dividend; updates outlook","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $1,788.8M (+7.4% YoY); net income $117.2M (+37.4%); GAAP EPS $0.75 (+33.9%).","Adjusted EPS $0.77 (+37.5% YoY); Adjusted EBITDA $261.9M (+22.4% YoY).","Critical illness recovery hospital segment adjusted EBITDA $115.9M (+51.0%); margin improved to 17.7%.","Reaffirms 2024 revenue outlook $6.9-7.1B; adjusts EBITDA outlook to $845-885M; adj EPS outlook $1.96-2.20.","Declares cash dividend $0.125 per share, payable May 30, 2024 to holders of record May 16."],"consensus_eps_estimate":null,"consensus_eps_actual":0.75,"consensus_revenue_estimate":null,"consensus_revenue_actual":1788809000.0,"consensus_period":"2024-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":2045678501.216232,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":221517,"accession_number":"0001104659-24-052995","cik":1320414,"company_name":"SELECT MEDICAL HOLDINGS CORP","ticker":"SEM","form_type":"8-K","filed_at":"2024-04-26T23:59:59+00:00","items":["5.02","5.03","5.07","9.01"],"status":"ready","headline":"Shareholders approve expanded equity plan and officer exculpation at annual meeting","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Shareholders approved amendment to 2020 Equity Incentive Plan, increasing share reserve to 5,925,000 shares and adding minimum one-year vesting.","Shareholders approved charter amendment to exculpate officers from certain fiduciary duty breaches, effective April 26, 2024.","Three Class III directors (Ely, Ortenzio, Scully) re-elected; non-binding advisory votes on executive compensation and simple majority proposal passed.","Ratification of PricewaterhouseCoopers as independent auditor for fiscal year 2024 approved with 122,477,547 votes for.","All seven proposals at the April 25, 2024 Annual Meeting were approved."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"market_cap_usd":2045678501.216232,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}